Aclarion announces $3M public offering

Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.

Advertisement

The company listed 5,175,000 units at  58 cents each, according to a news release.

In the last year, Aclarion has leveraged the expertise of spine surgeons including Roger Härtl, MD, to develop its Nociscan platform for diagnosing lower back pain. Alphatec also partnered with the company to include Nociscan with its AlphaInformatiX spine platform.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.